Curis Inc (CRIS) Stock Analysis

Curis Inc (CRIS) is a publicly traded company in the HEALTHCARE sector. It trades at $0.50, carries a market capitalization of $20.41M. This page summarizes the public market data, fundamentals, and frequently asked questions for CRIS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.50
• Market Cap: $20.41M
• EPS: $-0.58
• 52-Week High: $3.13
• 52-Week Low: $0.46

Market Sentiment

Curis Inc currently has a Bullish sentiment score of 0.27.

About Curis Inc

Curis, Inc. (Ticker: CRIS) is a biotechnology company based in Lexington, Massachusetts, committed to developing targeted therapies to address significant unmet medical needs in oncology. Through its innovative proprietary platforms, Curis focuses on advancing novel drug candidates aimed at treating various cancers, thereby enhancing patient outcomes within this critical therapeutic area. With a strategic emphasis on research and development, Curis is poised to play a pivotal role in the futu...

GNG Research Analysis

GNG Research scores Curis Inc (CRIS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CRIS.

Frequently Asked Questions

Does CRIS pay dividends?

Curis Inc (CRIS) does not currently pay a regular dividend.

What is CRIS's market cap?

Curis Inc (CRIS) has a market capitalization of $20.41M with a current stock price of $0.50.